The Lancet Gastroenterology & Hepatology in conversation with
Un pódcast de The Lancet Group
88 Episodo
-
Tim Vanuytsel on spore-forming probiotics in functional dyspepsia
Publicado: 9/9/2021 -
Raymond Henderson on the economic burden of colorectal cancer
Publicado: 12/8/2021 -
Sigurður Ólafsson on eliminating hepatitis C in Iceland
Publicado: 22/6/2021 -
Caroline Ovadia on intrahepatic cholestasis of pregnancy
Publicado: 3/6/2021 -
Matthew Akiyama on hepatitis C in prisons
Publicado: 12/4/2021 -
Monika Sarkar on reproductive health in women with liver disease
Publicado: 11/3/2021 -
Colorectal cancer risk in patients with Crohn’s disease
Publicado: 12/3/2020 -
Liver damage in young adults
Publicado: 17/1/2020 -
Treatments for IBS
Publicado: 14/1/2020 -
Statins and decompensated cirrhosis
Publicado: 27/11/2019 -
Global burden of pancreatic cancer and colorectal cancer
Publicado: 4/11/2019 -
Paediatric inflammatory bowel disease
Publicado: 12/9/2019 -
Transplanting hepatitis C-infected hearts
Publicado: 28/8/2019 -
Primary anastomosis as a treatment for diverticulitis
Publicado: 31/7/2019 -
Faecal microbiota transplantation in IBS
Publicado: 30/7/2019 -
Treating faecal incontinence in women
Publicado: 17/7/2019 -
Viral hepatitis in children & adolescents
Publicado: 23/5/2019 -
Whole-body MRI: the STREAMLINE trials
Publicado: 11/5/2019 -
A new drug for short bowel syndrome
Publicado: 5/4/2019 -
Eosinophilic oesophagitis endotype classification
Publicado: 9/3/2019
Hugh Thomas, Deputy Editor at The Lancet Gastroenterology & Hepatology, in conversation with the journal’s authors, explores their latest research and its impact on people’s health, healthcare, and health policy.A monthly audio companion to the journal, this podcast covers a broad range of topics, from predicting clinical outcomes in NAFLD to immunosuppressant withdrawal in patients with Crohn’s disease, the primary antibiotic resistance of Helicobacter pylori to surgical versus non-surgical management of malignant bowel obstruction, and more.
